
Anish Gupta
Examiner (ID: 17158)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1811, 6221, PCTL, IPLA, 1653 |
| Total Applications | 1025 |
| Issued Applications | 530 |
| Pending Applications | 179 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5793999
[patent_doc_number] => 20060014680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Peptides and compounds that bind to the IL-5 receptor'
[patent_app_type] => utility
[patent_app_number] => 10/890546
[patent_app_country] => US
[patent_app_date] => 2004-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9231
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10890546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/890546 | Peptides and compounds that bind to the IL-5 receptor | Jul 12, 2004 | Abandoned |
Array
(
[id] => 584656
[patent_doc_number] => 07438900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Dendritic encapsulation of active agents'
[patent_app_type] => utility
[patent_app_number] => 10/885878
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4549
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/438/07438900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10885878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/885878 | Dendritic encapsulation of active agents | Jul 7, 2004 | Issued |
Array
(
[id] => 5120511
[patent_doc_number] => 20070142226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof'
[patent_app_type] => utility
[patent_app_number] => 10/563637
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 35363
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142226.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563637 | Method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof | Jul 6, 2004 | Abandoned |
Array
(
[id] => 6972263
[patent_doc_number] => 20050037973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Compounds and methods for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 10/885482
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20018
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037973.pdf
[firstpage_image] =>[orig_patent_app_number] => 10885482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/885482 | Compounds and methods for cancer therapy | Jul 5, 2004 | Abandoned |
Array
(
[id] => 7217980
[patent_doc_number] => 20050054818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Crystalline compositions for controlling blood glucose'
[patent_app_type] => utility
[patent_app_number] => 10/880884
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12111
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10880884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/880884 | Crystalline compositions for controlling blood glucose | Jun 29, 2004 | Abandoned |
Array
(
[id] => 7265310
[patent_doc_number] => 20040242846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Method for the preparation of molecularly uniform hyperpolymeric hemoglobins'
[patent_app_type] => new
[patent_app_number] => 10/878724
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2780
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10878724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/878724 | Method for the preparation of molecularly uniform hyperpolymeric hemoglobins | Jun 27, 2004 | Abandoned |
Array
(
[id] => 7264928
[patent_doc_number] => 20040242464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Non-pyrogenic, endotoxin-frei stroma-free tetrameric hemoglobin'
[patent_app_type] => new
[patent_app_number] => 10/876541
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9792
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242464.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876541
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876541 | Non-pyrogenic, endotoxin-frei stroma-free tetrameric hemoglobin | Jun 27, 2004 | Abandoned |
Array
(
[id] => 7329787
[patent_doc_number] => 20040254115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator'
[patent_app_type] => new
[patent_app_number] => 10/865661
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14890
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865661 | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator | Jun 9, 2004 | Issued |
Array
(
[id] => 7319591
[patent_doc_number] => 20040225120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Process for purifying a compound'
[patent_app_type] => new
[patent_app_number] => 10/863456
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10753
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225120.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863456
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863456 | Process for purifying a compound | Jun 7, 2004 | Issued |
Array
(
[id] => 263776
[patent_doc_number] => 07569541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/559010
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7656
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569541.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559010
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559010 | Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines | Jun 1, 2004 | Issued |
Array
(
[id] => 4999826
[patent_doc_number] => 20070042460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Oxidation of peptides'
[patent_app_type] => utility
[patent_app_number] => 10/558958
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1592
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558958
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558958 | Oxidation of peptides | May 27, 2004 | Abandoned |
Array
(
[id] => 7297174
[patent_doc_number] => 20040214747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Method for administering monomeric insulin'
[patent_app_type] => new
[patent_app_number] => 10/852568
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7334
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214747.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852568 | Method for administering monomeric insulin | May 23, 2004 | Abandoned |
Array
(
[id] => 582632
[patent_doc_number] => 07449443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-11
[patent_title] => 'Method for stabilization of proteins using non-natural amino acids'
[patent_app_type] => utility
[patent_app_number] => 10/851564
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10309
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449443.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851564 | Method for stabilization of proteins using non-natural amino acids | May 20, 2004 | Issued |
Array
(
[id] => 7297232
[patent_doc_number] => 20040214781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same'
[patent_app_type] => new
[patent_app_number] => 10/851617
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5719
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851617 | Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same | May 20, 2004 | Abandoned |
Array
(
[id] => 7083797
[patent_doc_number] => 20050049177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Stable analogs of peptide and polypeptide therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/847220
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20931
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049177.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847220 | Stable analogs of peptide and polypeptide therapeutics | May 16, 2004 | Issued |
Array
(
[id] => 5259886
[patent_doc_number] => 20070213518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Novel Lipolytic Enzyme Lip2'
[patent_app_type] => utility
[patent_app_number] => 10/555560
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14347
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555560
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555560 | Novel Lipolytic Enzyme Lip2 | May 11, 2004 | Abandoned |
Array
(
[id] => 7441635
[patent_doc_number] => 20040185539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols'
[patent_app_type] => new
[patent_app_number] => 10/472042
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4611
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472042
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472042 | Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols | May 3, 2004 | Abandoned |
Array
(
[id] => 7038939
[patent_doc_number] => 20050158373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Method and carrier complexes for delivering molecules to cells'
[patent_app_type] => utility
[patent_app_number] => 10/838135
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17255
[patent_no_of_claims] => 123
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838135
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838135 | Method and carrier complexes for delivering molecules to cells | May 2, 2004 | Issued |
Array
(
[id] => 4927883
[patent_doc_number] => 20080167246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Ophthalmic and Contact Lens Solutions Containing Peptides as Preservative'
[patent_app_type] => utility
[patent_app_number] => 10/593352
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3305
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167246.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593352
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593352 | Ophthalmic and contact lens solutions containing peptides as preservative | Apr 14, 2004 | Issued |
Array
(
[id] => 4872688
[patent_doc_number] => 20080199422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline'
[patent_app_type] => utility
[patent_app_number] => 11/547926
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18069
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547926
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547926 | Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline | Apr 13, 2004 | Abandoned |